Frederick A. Brookfield

720 total citations
10 papers, 336 citations indexed

About

Frederick A. Brookfield is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Frederick A. Brookfield has authored 10 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 2 papers in Organic Chemistry. Recurrent topics in Frederick A. Brookfield's work include Blood properties and coagulation (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Genetic Neurodegenerative Diseases (2 papers). Frederick A. Brookfield is often cited by papers focused on Blood properties and coagulation (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Genetic Neurodegenerative Diseases (2 papers). Frederick A. Brookfield collaborates with scholars based in United Kingdom, Germany and United States. Frederick A. Brookfield's co-authors include Stephen M. Courtney, Michael E. Prime, Kevin J. Merchant, Graeme I. Stevenson, Margaret A. Cascieri, Matteo Aldeghi, Alexander Heifetz, Fintan Kelleher, Zhonghua Pei and Christopher J. Swain and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Bioorganic & Medicinal Chemistry.

In The Last Decade

Frederick A. Brookfield

10 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederick A. Brookfield United Kingdom 10 187 80 63 48 42 10 336
Catherine Bardelle United Kingdom 12 237 1.3× 47 0.6× 96 1.5× 23 0.5× 66 1.6× 20 395
Dorien Clarisse Belgium 12 201 1.1× 79 1.0× 33 0.5× 24 0.5× 79 1.9× 25 487
Amanda Cobos‐Correa Switzerland 6 192 1.0× 43 0.5× 21 0.3× 77 1.6× 34 0.8× 9 385
Afshin Bahador United States 10 314 1.7× 47 0.6× 41 0.7× 20 0.4× 43 1.0× 19 496
Laura Caboni Ireland 9 289 1.5× 76 0.9× 15 0.2× 51 1.1× 74 1.8× 11 441
James R. Porter United States 8 350 1.9× 60 0.8× 23 0.4× 49 1.0× 59 1.4× 12 483
Chong‐Qing Sun United States 10 164 0.9× 106 1.3× 24 0.4× 51 1.1× 39 0.9× 15 350
Niyada Hin United States 13 223 1.2× 79 1.0× 93 1.5× 60 1.3× 60 1.4× 24 447
Janet G. Mulheron United States 9 276 1.5× 143 1.8× 106 1.7× 51 1.1× 144 3.4× 10 488
Koc-Kan Ho United States 12 328 1.8× 64 0.8× 26 0.4× 16 0.3× 73 1.7× 17 476

Countries citing papers authored by Frederick A. Brookfield

Since Specialization
Citations

This map shows the geographic impact of Frederick A. Brookfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick A. Brookfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick A. Brookfield more than expected).

Fields of papers citing papers by Frederick A. Brookfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick A. Brookfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick A. Brookfield. The network helps show where Frederick A. Brookfield may publish in the future.

Co-authorship network of co-authors of Frederick A. Brookfield

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick A. Brookfield. A scholar is included among the top collaborators of Frederick A. Brookfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick A. Brookfield. Frederick A. Brookfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Heifetz, Alexander, Matteo Aldeghi, Colin H. MacKinnon, et al.. (2016). Fragment Molecular Orbital Method Applied to Lead Optimization of Novel Interleukin-2 Inducible T-Cell Kinase (ITK) Inhibitors. Journal of Medicinal Chemistry. 59(9). 4352–4363. 64 indexed citations
2.
Prime, Michael E., Frederick A. Brookfield, Stephen M. Courtney, et al.. (2012). Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease. ACS Medicinal Chemistry Letters. 3(9). 731–735. 19 indexed citations
3.
Wityak, John, Michael E. Prime, Frederick A. Brookfield, et al.. (2012). SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease. ACS Medicinal Chemistry Letters. 3(12). 1024–1028. 30 indexed citations
4.
Maillard, Michel, Frederick A. Brookfield, Stephen M. Courtney, et al.. (2011). Exploiting differences in caspase-2 and -3 S2 subsites for selectivity: Structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors. Bioorganic & Medicinal Chemistry. 19(19). 5833–5851. 29 indexed citations
5.
Prime, Michael E., Stephen M. Courtney, Frederick A. Brookfield, et al.. (2010). Phthalazinone Pyrazoles as Potent, Selective, and Orally Bioavailable Inhibitors of Aurora-A Kinase. Journal of Medicinal Chemistry. 54(1). 312–319. 73 indexed citations
6.
Duff, Stephen M. G., Y. Gopichand, Bruce C. Hamper, et al.. (2006). The carboxyterminal processing protease of D1 protein: Herbicidal activity of novel inhibitors of the recombinant and native spinach enzymes. Pesticide Biochemistry and Physiology. 88(1). 1–13. 9 indexed citations
7.
Armer, Richard, Mark Ashton, Frederick A. Brookfield, et al.. (2005). Indole-3-acetic Acid Antagonists of the Prostaglandin D2 Receptor CRTH2. Journal of Medicinal Chemistry. 48(20). 6174–6177. 39 indexed citations
8.
Pons, Jean‐François, et al.. (2000). Thiazole formation via traceless cleavage of Rink resin. Tetrahedron Letters. 41(25). 4965–4968. 12 indexed citations
9.
Schwender, Charles F., et al.. (1998). Novel modified tripeptide inhibitors of α4β7 mediated lymphoid cell adhesion to MAdCAM-1. Bioorganic & Medicinal Chemistry Letters. 8(13). 1601–1606. 9 indexed citations
10.
MacLeod, Angus M., Kevin J. Merchant, Frederick A. Brookfield, et al.. (1994). Identification of L-Tryptophan Derivatives with Potent and Selective Antagonist Activity at the NK1 Receptor. Journal of Medicinal Chemistry. 37(9). 1269–1274. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Bardelle Breakdown of academic impact, for papers by Dorien Clarisse Breakdown of academic impact, for papers by Amanda Cobos‐Correa Breakdown of academic impact, for papers by Afshin Bahador Breakdown of academic impact, for papers by Laura Caboni Breakdown of academic impact, for papers by James R. Porter Breakdown of academic impact, for papers by Chong‐Qing Sun Breakdown of academic impact, for papers by Niyada Hin Breakdown of academic impact, for papers by Janet G. Mulheron Breakdown of academic impact, for papers by Koc-Kan Ho
Rankless by CCL
2026